Dataciencia

Colección SciELO Chile

Evaluation of the Response of Unresectable Primary Cutaneous Melanoma to Immunotherapy Visualized With Reflectance Confocal Microscopy A Report of 2 Cases

Indexado

WoS	WOS:000461059000012
Scopus	SCOPUS_ID:85059963872

DOI

10.1001/JAMADERMATOL.2018.3688

Año

2019

Tipo

artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

CONCLUSIONS AND RELEVANCE Although RCM will not replace larger field imaging (such as magnetic resonance imaging, positron emission tomography, and computed tomography) in the management and follow-up of melanoma or other tumors, for imaging of cutaneous involvement and disease monitoring, RCM holds promise as a novel noninvasive technique.

Revista

Revista	ISSN
Jama Dermatology	2168-6068

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Dermatology

Scopus
Sin Disciplinas

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	NAVARRETE-DECHENT, CRISTIAN PATRICIO	Hombre	Mem Sloan Kettering Canc Ctr - Estados Unidos Pontificia Universidad Católica de Chile - Chile Memorial Sloan-Kettering Cancer Center - Estados Unidos Facultad de Medicina - Chile
2	Cordova, Miguel	Hombre	Mem Sloan Kettering Canc Ctr - Estados Unidos Memorial Sloan-Kettering Cancer Center - Estados Unidos
3	Postow, Michael A.	Hombre	Mem Sloan Kettering Canc Ctr - Estados Unidos Weill Cornell Med Coll - Estados Unidos Memorial Sloan-Kettering Cancer Center - Estados Unidos Weill Cornell Medical College - Estados Unidos Weill Cornell Medicine - Estados Unidos
4	Pulitzer, Melissa	Mujer	Mem Sloan Kettering Canc Ctr - Estados Unidos Memorial Sloan-Kettering Cancer Center - Estados Unidos
5	Lezcano, Cecilia	Mujer	Mem Sloan Kettering Canc Ctr - Estados Unidos Memorial Sloan-Kettering Cancer Center - Estados Unidos
6	Halpern, Allan C.	Hombre	Mem Sloan Kettering Canc Ctr - Estados Unidos Memorial Sloan-Kettering Cancer Center - Estados Unidos
7	Rossi, A. M.	Hombre	Mem Sloan Kettering Canc Ctr - Estados Unidos Weill Cornell Med Coll - Estados Unidos Memorial Sloan-Kettering Cancer Center - Estados Unidos Weill Cornell Medical College - Estados Unidos Weill Cornell Medicine - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Origen de Citas Identificadas

Muestra la distribución de países cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 7.69 %
Citas No-identificadas: 92.31 %

Muestra la distribución de instituciones nacionales o extranjeras cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 7.69 %
Citas No-identificadas: 92.31 %

Financiamiento

Fuente
National Institutes of Health
National Cancer Institute
National Cancer Institute/National Institutes of Health
Skin Cancer Foundation
Allergan Foundation
Memorial Sloan-Kettering Cancer Center
American Society for Laser Medicine and Surgery A. Ward Ford Memorial Research
LAM Therapeutics

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
This research is funded in part by a grant from the National Cancer Institute/National Institutes of Health (P30-CA008748) made to the Memorial Sloan Kettering Cancer Center.
travel accommodation from Mavig; he is also a consultant for Merz, DynaMed, Canfield Scientific, Evolus, Biofrontera, QuantiaMD, Lam Therapeutics, and Cutera; is on the advisory board of Allergan; and is supported by the American Society for Laser Medicine and Surgery A. Ward Ford Memorial Research Grant as well as a research grant from the Skin Cancer Foundation. Dr Postow reports consulting fees from Bristol-Myers Squibb, Merck, Array BioPharma, Novartis, Incyte, NewLink Genetics, and Aduro Biotech; honoraria from Bristol-Myers Squibb and Merck; and institutional support from Rgenix, Infinity, Bristol-Myers Squibb, Merck, Array BioPharma, and Novartis. No other disclosures were reported.

Agradecimiento

This research is funded in part by a grant from the National Cancer Institute/National Institutes of Health (P30-CA008748) made to the Memorial Sloan Kettering Cancer Center.

travel accommodation from Mavig; he is also a consultant for Merz, DynaMed, Canfield Scientific, Evolus, Biofrontera, QuantiaMD, Lam Therapeutics, and Cutera; is on the advisory board of Allergan; and is supported by the American Society for Laser Medicine and Surgery A. Ward Ford Memorial Research Grant as well as a research grant from the Skin Cancer Foundation. Dr Postow reports consulting fees from Bristol-Myers Squibb, Merck, Array BioPharma, Novartis, Incyte, NewLink Genetics, and Aduro Biotech; honoraria from Bristol-Myers Squibb and Merck; and institutional support from Rgenix, Infinity, Bristol-Myers Squibb, Merck, Array BioPharma, and Novartis. No other disclosures were reported.